Article metrics
PDF
Other content recommended for you
- Drugs to prevent vascular events after stroke
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
- Prevention of ischaemic stroke
- Concurrent intracranial and extracranial artery stenosis and the prognosis of transient ischaemic symptoms or imaging-negative ischaemic stroke
- Should I start all my ischaemic stroke and TIA patients on a statin, an ACE inhibitor, a diuretic, and aspirin today?
- Retinal microvascular signs and recurrent vascular events in patients with TIA or minor stroke
- Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke
- Long term risks of stroke, myocardial infarction, and vascular death in “low risk” patients with a non-recent transient ischaemic attack
- Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis
- Antithrombotic treatment in atrial fibrillation